Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

The company's shares rose as investors breathed a sigh of relief on strong sales growth and guidance, despite ongoing ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

More and more people are taking weight loss injectables like Wegovy and Mounjaro — and pharmacy experts are worried that not everyone prescribed these drugs should have access to them. As Women's ...